Financials Myriad Genetics, Inc.

Equities

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 03:59:51 2024-02-22 pm EST 5-day change 1st Jan Change
23.1 USD +0.81% Intraday chart for Myriad Genetics, Inc. -2.10% +20.66%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 2,173 2,026 1,487 2,204 1,176 2,031 2,031 -
Enterprise Value (EV) 1 2,002 2,122 1,595 1,864 1,061 2,042 2,090 2,099
P/E ratio 16 x 454 x -6.42 x -78.9 x -10.4 x -7.33 x -21.3 x -31.2 x
Yield - - - - - - - -
Capitalization / Revenue 2.81 x 2.38 x 2.67 x 3.19 x 1.73 x 2.7 x 2.47 x 2.29 x
EV / Revenue 2.59 x 2.49 x 2.86 x 2.7 x 1.56 x 2.72 x 2.55 x 2.37 x
EV / EBITDA 12.1 x 9.73 x - 25.9 x -50.5 x -160 x 208 x 64 x
EV / FCF 18.6 x 28.3 x -24.7 x 11.5 x -7 x 75.6 x 2,090 x 140 x
FCF Yield 5.37% 3.54% -4.05% 8.7% -14.3% 1.32% 0.05% 0.71%
Price to Book 2.13 x 1.84 x 1.69 x 2.28 x 1.33 x 2.81 x 2.93 x 2.97 x
Nbr of stocks (in thousands) 74,762 74,389 75,210 79,855 81,034 88,669 88,669 -
Reference price 2 29.07 27.23 19.78 27.60 14.51 22.91 22.91 22.91
Announcement Date 8/21/18 8/13/19 2/23/21 2/24/22 2/28/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 772.6 851.1 557 690.6 678.4 751.2 820.9 886
EBITDA 1 164.8 218.2 - 71.9 -21 -12.75 10.06 32.79
EBIT 1 110.4 145.2 -77.9 9.1 -32.8 -29.7 2.488 27.44
Operating Margin 14.29% 17.06% -13.99% 1.32% -4.83% -3.95% 0.3% 3.1%
Earnings before Tax (EBT) 1 116.9 - - -57.1 -140.6 -262.6 -101.3 -71.3
Net income 1 131 4.6 - -27.2 -112 -256.4 -90.21 -63.18
Net margin 16.96% 0.54% - -3.94% -16.51% -34.13% -10.99% -7.13%
EPS 2 1.820 0.0600 -3.080 -0.3500 -1.390 -3.128 -1.075 -0.7350
Free Cash Flow 1 107.5 75.1 -64.6 162.2 -151.6 27 1 15
FCF margin 13.91% 8.82% -11.6% 23.49% -22.35% 3.59% 0.12% 1.69%
FCF Conversion (EBITDA) 65.23% 34.42% - 225.59% - - 9.94% 45.74%
FCF Conversion (Net income) 82.06% 1,632.61% - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 8/21/18 8/13/19 2/23/21 2/24/22 2/28/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 189.4 167.3 160.8 164.9 179.3 156.4 177.8 181.2 183.5 191.9 194.6 195.9 204.3 207.1 213.7
EBITDA 1 30.4 12.8 13.4 10.2 7.3 -17.6 -10.7 -9.9 -4.2 1.2 5.25 0.2 -0.4 2.2 1.8
EBIT 1 13.5 -1.4 0.1 -2.8 4.5 -20.6 -13.9 -21.9 -6.8 -2.2 1.199 -3.729 1.298 1.212 5.179
Operating Margin 7.13% -0.84% 0.06% -1.7% 2.51% -13.17% -7.82% -12.09% -3.71% -1.15% 0.62% -1.9% 0.64% 0.59% 2.42%
Earnings before Tax (EBT) 1 -3.8 39.8 -43.5 -26.4 -17.9 -44.2 -52.1 -52.6 -116.1 -61.2 -30.52 -27.39 -22.91 -25.35 -19.19
Net income 1 -4.7 24.6 -7.6 -20.5 -14.1 -35.1 -42.3 -54.7 -116.1 -61.3 -24.47 -25.05 -20.09 -22.39 -16.48
Net margin -2.48% 14.7% -4.73% -12.43% -7.86% -22.44% -23.79% -30.19% -63.27% -31.94% -12.57% -12.79% -9.84% -10.81% -7.71%
EPS 2 -0.0600 0.3000 -0.1000 -0.2600 -0.1800 -0.4300 -0.5200 -0.6700 -1.420 -0.7500 -0.2925 -0.2967 -0.2367 -0.2600 -0.1933
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 8/3/21 11/2/21 2/24/22 5/5/22 8/4/22 11/1/22 2/28/23 5/3/23 8/3/23 11/6/23 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - 96.6 108 - - 10.2 59 67.6
Net Cash position 1 171 - - 340 115 - - -
Leverage (Debt/EBITDA) - 0.4427 x - - - -0.7986 x 5.864 x 2.062 x
Free Cash Flow 1 108 75.1 -64.6 162 -152 27 1 15
ROE (net income / shareholders' equity) 15.1% 12.4% -5.6% 0.15% -12.1% -2.9% -1.51% 2.07%
ROA (Net income/ Total Assets) 11% 9.27% -3.57% 0.1% -1.92% -2.13% -0.9% 1.23%
Assets 1 1,191 49.62 - -26,667 5,830 12,065 10,001 -5,153
Book Value Per Share 2 13.70 14.80 11.70 12.10 10.90 8.160 7.810 7.720
Cash Flow per Share 2 1.610 1.100 - 0.2300 -1.320 -0.0400 0.3700 -
Capex 1 8.4 8.6 10.2 18 45.3 33.5 18 20
Capex / Sales 1.09% 1.01% 1.83% 2.61% 6.68% 4.46% 2.19% 2.26%
Announcement Date 8/21/18 8/13/19 2/23/21 2/24/22 2/28/23 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
C
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
12
Last Close Price
22.91 USD
Average target price
22.5 USD
Spread / Average Target
-1.79%
Consensus
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer